Morgan Stanley raised the firm’s price target on American Healthcare REIT (AHR) to $29 from $27 and keeps an Overweight rating on the shares after updating estimates to reflect Q3 earnings and mark to market the multiple based on where healthcare peers have traded.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AHR:
- American Healthcare REIT Announces Quarterly Distribution
- American Healthcare REIT price target raised to $30 from $28 at RBC Capital
- American Healthcare REIT price target raised to $36 from $31 at BofA
- American Healthcare REIT price target raised to $29 from $27 at Truist
- American Healthcare REIT, Inc. Reports Q3 2024 Results
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
